Pfizer will halt its development of a weight-loss drug that was being closely watched by investors, in a significant blow to the US pharmaceutical group.
輝瑞(Pfizer)將停止開發(fā)其備受投資者關(guān)注的減肥藥，這對(duì)這家美國制藥集團(tuán)來說是一個(gè)重大打擊。
您已閱讀5%（201字），剩余95%（3873字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。